(Q52915154)

9 May 2018

title

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy. (English)

1 reference

9 May 2018

0 references

1 reference

1 reference

D Luo

1

1 reference

9 May 2018

H Ren

2

1 reference

9 May 2018

T Li

3

1 reference

9 May 2018

K Lian

4

1 reference

9 May 2018

D Lin

5

1 reference

9 May 2018

language of work or name

English

0 references

publication date

22 September 2015

1 reference

9 May 2018

Osteoporosis International

published in

1 reference

9 May 2018

volume

27

1 reference

9 May 2018

issue

3

1 reference

9 May 2018

page(s)

1093-1101

1 reference

9 May 2018

Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EF

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

21 January 2018

What old means to bone

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Osteocyte-driven bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Autophagy in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Glucocorticoid-induced autophagy in osteocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Suppression of autophagy in osteocytes mimics skeletal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Autophagy activation by rapamycin reduces severity of experimental osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Male rodent model of age-related bone loss in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Bone structure and metabolism in a rodent model of male senile osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

21 January 2018

The amazing osteocyte

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Osteocyte: the unrecognized side of bone tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-015-3325-5

Identification of apoptotic changes in osteocytes in normal and pathological human bone

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26395886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26395886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26395886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00198-015-3325-5

1 reference

9 May 2018

1 reference

9 May 2018